Biopharma Absci Prices US$200 Million IPO

Synthetic biology company Absci Corporation began trading on the Nasdaq Global Select Market today under the symbol “ABSI”. The firm’s initial public offering is looking to raise US$200.0 million and is expected to close on July 26, 2021.

The offering consists of 12,500,000 common shares selling at US$16.00 per share. This puts the company valuation at approximately US$1.5 billion.

The company granted a 30-day over-allotment option to purchase additional 1,875,000 common shares at the same IPO price, potentially bringing total offering proceeds up to US$230.0 million. J.P. Morgan, Credit Suisse, BofA Securities, Cowen, and Stifel are all acting as joint bookrunners for the said offering.

The Washington-based biopharma company uses technology to develop the potential role of proteins in therapeutics.


Information for this briefing was found via Sedar and Absci. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Tudor Gold x American Creek: Consolidating A Massive Gold Project

Aura Minerals: The Era Dorada Underground PEA

Gold Is Now Smart Money’s End Game | Doug Casey

Recommended

Goliath Resources Closes Out Funding Round With Total Gross Proceeds Of $27.1 Million

Silver47 Kickstarts 4,000 Metre Drill Campaign At Red Mountain Project

Related News

SPAC Portage Fintech Acquisition Upsizes IPO To US$240 Million

Special purpose acquisition company Portage Fintech Acquisition Corporation (Nasdaq: PFTAU) announced Tuesday that it is...

Wednesday, July 21, 2021, 12:03:00 PM

Robinhood Creating Platform to Allow Amateur Investors to Buy IPOs, Including its Own

While still brushing off daytrader anguish and congressional scrutiny after its decision to pause trading...

Saturday, March 27, 2021, 11:21:00 AM

Foodservice SPAC Banyan Acquisition Aims To Conduct A US$210 Million IPO

Blank check company Banyan Acquisition Corporation (NYSE: BYN.U) is looking to raise US$210 million for...

Thursday, January 20, 2022, 02:24:00 PM

Restaurant Operator Yoshiharu Prices Upsized US$11.8 Million IPO

Restaurant operator Yoshiharu Global Co. (Nasdaq: YOSH) started trading on the Nasdaq Capital Market on...

Friday, September 9, 2022, 02:22:00 PM

Healthcare SPAC Healthwell Acquisition Aims To Raise US$250 Million In IPO

Special purpose acquisition company Healthwell Acquisition Corp. I (NASDAQ: HWELU) went public on the Nasdaq...

Wednesday, August 4, 2021, 11:57:00 AM